A Switzerland-based multi-family office where partners join forces to invest in public and private markets through meaningful impact investments.
About Us
Numan Wealth Partners is a conviction-driven Multi-Family Office, established by leading Swiss families, aiming to deliver superior returns through value creation across all asset classes.
We are licensed by the Swiss Financial Market Supervisory Authority (FINMA) and monitored by SOFIT, a FINMA-authorized supervisory body that oversees asset managers.
Our Expertise and Beyond
Numan Wealth Partners combines the Dumas family’s historical expertise in Real Estate and our know-how in Public and Private Markets. Our Senior Management Team benefits from over 120 years of Financial Expertise acquired worldwide and across various Asset Classes.
By offering our partners best-in-class and tailor-made investment solutions in traditional and emerging Asset Classes, we aim to generate above-average returns over the long- term.
.png)
.jpg)
The Numan Approach
Our family wealth management is rooted in an open architecture model.
In addition to our in-house expertise in Public Markets via Advisory or Discretionary Portfolio Management solutions, we offer broad access to Private Markets, including Venture Capital and Private Debt. Our access to top-tier partner solutions provides clear Added Value and Portfolio Diversification to our Partners.
Some of our impact investments
.png)
Creating the first ever eco-aligned watches; recycled. circular and Swiss-made.
.png)
A leading scale-up offering FDA approved Point-of-care diagnostic solutions. Won the Swiss Medtech award 2023.
.png)
Funds sustainable tech by linking investors with Article 9-aligned investments.
.png)
Germany's first greentech unicorn and among the largest residential solar installers in Europe.
Tech firm delivering portfolio consolidation, impact metrics and a streamlined ecosystem.
.png)
The first on demand robotics system, designed to optimize how you perform minimally invasive surgery.
.png)
Climate Deep-Tech solving the methane and GHG challenge in though-to-decarbonise industries, leading the way to Net-Zero.
.png)
Leveraging the power of the dark genome to develop precise and potent RNA therapies.
Contact Us
